David Deng Bio

David Dend, M.D., Ph.D.

Co-Founder, CTO

Accomplished physician-scientist and entrepreneur with a strong track record of shaping the future of diagnostics and precision medicine

Over two decades of leadership experience across cutting-edge biotech firms in the US, pioneering innovations in genomics, prenatal testing, and personalized healthcare

Played a pivotal role in multiple transformative ventures:

Agilent Technologies (2000–2007): Early champion of microfluidics for diagnostics; helped guide Agilent’s expansion into clinical applications

Artemis/Verinata/Illumina (2007–2010): As VP, helped lead the development of the first non-invasive prenatal test (NIPT); Verinata was acquired by Illumina for $450M

Ion Torrent / Thermo Fisher (2010–2014): Spearheaded development and regulatory strategy for next-generation sequencing (NGS) platforms

Founder of Ardent BioMed – a Silicon Valley and Guanzhou, China - based R&D and commercialization platform focused on breakthrough IVD and research technologies

Deep scientific expertise combined with strategic vision has enabled successful startup launches, FDA submissions, and M&A outcomes

Education: M.D. and M.S. – Shanghai Jiaotong University, Ph.D. – McGill University | Postdoctoral Fellow – UCSF